HUT64848A - Medical preparatives for preventing and treating osteoporises after menopausa - Google Patents

Medical preparatives for preventing and treating osteoporises after menopausa Download PDF

Info

Publication number
HUT64848A
HUT64848A HU9302183A HU9302183A HUT64848A HU T64848 A HUT64848 A HU T64848A HU 9302183 A HU9302183 A HU 9302183A HU 9302183 A HU9302183 A HU 9302183A HU T64848 A HUT64848 A HU T64848A
Authority
HU
Hungary
Prior art keywords
ipriflavone
estrogen
treatment
estrogens
day
Prior art date
Application number
HU9302183A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9302183D0 (en
Inventor
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of HU9302183D0 publication Critical patent/HU9302183D0/hu
Publication of HUT64848A publication Critical patent/HUT64848A/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9302183A 1991-02-01 1992-01-28 Medical preparatives for preventing and treating osteoporises after menopausa HUT64848A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910253A IT1244697B (it) 1991-02-01 1991-02-01 Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale

Publications (2)

Publication Number Publication Date
HU9302183D0 HU9302183D0 (en) 1993-10-28
HUT64848A true HUT64848A (en) 1994-03-28

Family

ID=11358374

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9302183A HUT64848A (en) 1991-02-01 1992-01-28 Medical preparatives for preventing and treating osteoporises after menopausa

Country Status (9)

Country Link
EP (1) EP0569415A1 (it)
AU (1) AU1188492A (it)
CA (1) CA2101547A1 (it)
HU (1) HUT64848A (it)
IE (1) IE920219A1 (it)
IT (1) IT1244697B (it)
NZ (1) NZ241418A (it)
WO (1) WO1992013538A1 (it)
ZA (1) ZA92661B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023716A1 (en) * 1993-04-16 1994-10-27 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US6319914B1 (en) 1993-11-05 2001-11-20 Apollo Biopharmaceuticals, Inc. Cytoprotective effect of polycyclic phenolic compounds
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US6326365B1 (en) 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US6339078B1 (en) 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
BR0208165A (pt) * 2001-03-16 2004-03-30 Wyeth Corp Composições farmacêuticas e seus usos na terapia de reposição de estrogênio
CN101646433B (zh) * 2006-10-24 2011-11-16 戴维·W·克雷姆平 抗再吸收的和造骨的食物增补剂和使用方法

Also Published As

Publication number Publication date
IT1244697B (it) 1994-08-08
IE920219A1 (en) 1992-08-12
ZA92661B (en) 1992-10-28
AU1188492A (en) 1992-09-07
HU9302183D0 (en) 1993-10-28
ITMI910253A0 (it) 1991-02-01
CA2101547A1 (en) 1992-08-02
ITMI910253A1 (it) 1992-08-01
EP0569415A1 (en) 1993-11-18
WO1992013538A1 (en) 1992-08-20
NZ241418A (en) 1993-03-26

Similar Documents

Publication Publication Date Title
JP3113269B2 (ja) 骨粗鬆症治療剤
DE602004002591T2 (de) Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
JP3208482B2 (ja) 避妊製剤
EP0686037A1 (en) Hormone replacement therapy
GB2137496A (en) Use of fluoxetine as an anti-anxiety agent
JP2003095971A (ja) 骨粗鬆症治療剤または組成物
HUT64848A (en) Medical preparatives for preventing and treating osteoporises after menopausa
Breslau Calcium, estrogen, and progestin in the treatment of osteoporosis
AU2017206480B2 (en) Composition, containing Loganin or a derivative thereof as an active ingredient for preventing, remedying, or treating female climacteric syndrome
US4820736A (en) Use of clomiphene to predict fertility in a human female
EP3833370A1 (en) Compositions for use in the treatment of obesity
Nakamura et al. Treatment of uterine leiomyomata with a luteinizing hormonereleasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women
WO2008122439A2 (en) Dr0spiren0ne/17beta-estradi0l regimen, pharmaceutical combination product and kit for performing this regimen
Maddox Women at midlife: Hormone replacement therapy
JP3604710B2 (ja) 骨粗鬆症予防及び治療剤
RU2220712C1 (ru) Средство и набор для нормализации функциональных нарушений, возникающих в предклимактерический и климактерический период
KR102225792B1 (ko) 에키노크롬 a를 유효성분으로 함유하는 폐경기 증후군의 치료 또는 예방용 약학적 조성물
JP3248170B2 (ja) コンドロイチン硫酸蛋白複合体含有食品
US20220160734A1 (en) Treatment of fibroids with vitamin d and an agent such as epigallocatechin gallate (egcg)
AU692155B2 (en) Method and composition for treatment of osteoporosis
US11058737B2 (en) Use of Euycoma longifolia extract in alleviating symptoms and/or conditions associated with hormonal imbalance in females
Hale et al. Exploring the role of progestins and phytoestrogens in menopause
No Menopause and osteoporosis
Burke Therapeutic Strategies for Prevention
WO2025133964A1 (en) A nutraceutical formulation to treat hormonal imbalances and menstrual disorders

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal